Market Overview

Kindred Healthcare Offers Letter to Gentiva's Board

Related GTIV
Benzinga's M&A Chatter for Thursday October 9, 2014
Markets Drop; PepsiCo Earnings Top Estimates
Related KND
Benzinga's Volume Movers
UPDATE: Kindred Healthcare Announces 5M Proposed Public Offerings Of Common Stock And 150,000 Tangible Equity Units

Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE: KND) today sent
the following letter to the board of directors of Gentiva Health Services,
Inc. (“Gentiva”) (NASDAQ: GTIV) in response to Gentiva's announcement on July
17, 2014 that an unnamed party has purportedly submitted a proposal to acquire
Gentiva for $17.25 per share, subject to financing, due diligence, internal
approvals and other conditions.

July 21, 2014

Rodney Windley
Executive Chairman
Gentiva Health Services, Inc.
3350 Riverwood Parkway, Suite 1400
Atlanta, GA 30339

Tony Strange
Chief Executive Officer, President and Director
Gentiva Health Services, Inc.
3350 Riverwood Parkway, Suite 1400
Atlanta, GA 30339

Dear Rod and Tony:

I am writing following the recent discussions among our respective financial
advisors in response to the press release issued by Gentiva on July 17, 2014,
which stated that an unnamed party has submitted a proposal to acquire the
company for $17.25 per share in cash, subject to financing, due diligence,
internal approvals and other conditions.

As you know, for the last several months we have sought to engage with Gentiva
in order to negotiate mutually acceptable transaction terms for Kindred to
acquire 100% of the outstanding shares of Gentiva.

We have indicated our willingness to structure a transaction so that Gentiva
shareholders can receive all cash or a mix of cash and stock, which would
allow them to participate in the combined company's substantial upside
potential.

Additionally, we have been clear that we are willing to consider further
increasing our offer if you engage in good faith and permit us to conduct due
diligence. Specifically, we confirm that Kindred would be prepared to enter
into a negotiated agreement to acquire all of the outstanding shares of
Gentiva for $17.25 per share, provided that we are permitted to conduct
diligence to confirm such additional value is warranted.

As requested by your financial advisors, we also confirm that Kindred is
willing to enter into appropriate confidentiality and standstill agreements,
in order to facilitate discussions to combine our two companies.

This letter is not intended to create or constitute any legally binding
obligation, liability or commitment by us regarding a transaction or any other
matter. There will be no legally binding agreement between us regarding a
transaction unless and until a definitive agreement is executed.

We look forward to combining our two businesses and pursuing what we think is
an incredibly compelling opportunity for our collective shareholder groups,
patients and employees.

Please feel free to contact me with any questions.

Yours truly,

Paul J. Diaz
Chief Executive Officer
Kindred Healthcare, Inc.

cc: Phyllis Yale, Chairman of the Board

Posted-In: News Press Releases

 

Related Articles (GTIV + KND)

Around the Web, We're Loving...

Get Benzinga's Newsletters